Literature DB >> 2512683

Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents.

M A Packham1, N L Bryant, M A Guccione, R L Kinlough-Rathbone, J F Mustard.   

Abstract

The effect of the concentration of Ca2+ in the suspending medium of human and rabbit platelets on aggregation, release of 14C-serotonin, and TXB2 formation in response to ADP, thrombin, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (PAF), collagen and arachidonic acid was studied in either platelet-rich plasma anticoagulated with D-phenylalanyl-prolyl-arginyl chloromethylketone (PPACK) or citrate, or suspensions of washed platelets in modified Tyrode-albumin solutions containing 1 mM Mg2+ and concentrations of added Ca2+ ranging from 0 to 5 mM. In response to ADP, thrombin, or PAF, human platelets were stimulated to form TXA2 by close platelet contact in a low-Ca2+ medium; at physiological concentrations of Ca2+, TXB2 formation was much less and declined progressively as the concentration of Ca2+ was raised. When the formation of TXA2 was blocked with aspirin or indomethacin, aggregation and release by human platelets were strongest at physiological concentrations of Ca2+. Rabbit platelet responses differed markedly from those of human platelets because close contact of rabbit platelets in a low-Ca2+ medium did not promote TXA2 formation. Rabbit platelet responses were more strongly inhibited by the lack of added Ca2+ in the medium than the responses of human platelets, possibly because rabbit platelets do not contain releasable Ca2+. In all studies of human platelets in media with low concentrations of Ca2+, the additional contribution to platelet responses of TXA2 formed because of close platelet contact should be considered because TXA2 formation is not usually stimulated in this way at physiological concentrations of Ca2+.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512683

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

1.  Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro.

Authors:  Kiran Kumar R Mangalpally; Alan Siqueiros-Garcia; Muthiah Vaduganathan; Jing-Fei Dong; Neal S Kleiman; Sasidhar Guthikonda
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

Review 2.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

3.  Historical perspective on ADP-induced platelet activation.

Authors:  Marian A Packham; Margaret L Rand
Journal:  Purinergic Signal       Date:  2011-04-02       Impact factor: 3.765

4.  The H1-histamine antagonist Dithiaden inhibits human platelets in vitro.

Authors:  R Nosál; V Jancinová; E Danihelová
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

5.  Triplatin, a platelet aggregation inhibitor from the salivary gland of the triatomine vector of Chagas disease, binds to TXA(2) but does not interact with glycoprotein PVI.

Authors:  Dongying Ma; Teresa C F Assumpção; Yuan Li; John F Andersen; José Ribeiro; Ivo M B Francischetti
Journal:  Thromb Haemost       Date:  2011-12-08       Impact factor: 5.249

6.  ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors.

Authors:  G E Jarvis; R G Humphries; M J Robertson; P Leff
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

7.  Regulation and functional consequences of ADP receptor-mediated ERK2 activation in platelets.

Authors:  Analia Garcia; Haripriya Shankar; Swaminathan Murugappan; Soochong Kim; Satya P Kunapuli
Journal:  Biochem J       Date:  2007-06-01       Impact factor: 3.857

8.  Incorporation of lipids labeled with various fatty acids into the cytoskeleton of aggregating platelets.

Authors:  M A Packham; M A Guccione; N L Bryant; A Livne
Journal:  Lipids       Date:  1991-07       Impact factor: 1.880

9.  Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.

Authors:  M A Packham; A A Livne; D H Ruben; M L Rand
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

10.  In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation.

Authors:  P C J Armstrong; P D Leadbeater; M V Chan; N S Kirkby; J A Jakubowski; J A Mitchell; T D Warner
Journal:  J Thromb Haemost       Date:  2011-03       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.